VICTORIA BURT: Open Payments
NPI 1427122597 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,953 in 84 payments from 23 companies in 2025. Trend: 2023 $3,554 · 2024 $3,344 · 2025 $2,953
Food & beverage: $2,889Education: $64
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 11 | $442 |
| Lilly USA, LLC | 2 | $208 |
| Merck Sharp & Dohme LLC | 10 | $189 |
| Alnylam Pharmaceuticals Inc. | 2 | $175 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $155 |
| AstraZeneca Pharmaceuticals LP | 4 | $147 |
| E.R. Squibb & Sons, L.L.C. | 3 | $142 |
| Otsuka America Pharmaceutical, Inc. | 1 | $137 |
| Abbott Laboratories | 1 | $137 |
Products named: UPTRAVI, AMVUTTRA, LifeVest, JARDIANCE, REXULTI, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, LEQVIO, CAMZYOS.
Industry payments across GA — which companies pay providers there.
